Lakewood-Amedex Biotherapeutics
LABT
#10975
Rank
ยฃ3.98 M
Marketcap
ยฃ1.68
Share price
7.51%
Change (1 day)
N/A
Change (1 year)
Categories

Earnings for Lakewood-Amedex Biotherapeutics (LABT)

Earnings in 2026 (TTM): -ยฃ3.01 Million

According to Lakewood-Amedex Biotherapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ2.83 Million, an increase over its 2024 earnings that were of -ยฃ3.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lakewood-Amedex Biotherapeutics from 2023 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ3.01 Million6.25%
2025 -ยฃ2.83 Million-20.76%
2024 -ยฃ3.57 Million-41.37%
2023-ยฃ6.08 Million